Femoston conti

Medicinal product

(Invented) name

Femoston conti

Active substance (s)

Estradiolis/Didrogesteronas

Strength

1 mg/5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03FA14, Dydrogesterone and estrogen

Marketing authorisation holder

MagnaPharm SK s. r. o., Slovakija

Date of authorisation

2001-10-08

Date of renewal

2012-04-23

Documents

2903 Pakuotės lapelis 2024 12 23.docx

2903 Femoston conti PCS PL 2024 12 23.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Estradiolis	1 mg
Didrogesteronas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
1716	3544	1003544	lizdinė plokštelė	N28		Receptinis	LT/1/98/2903/001	Tiekiama	-	-	No	-	-	Download
10770	15311	1015311	lizdinė plokštelė	N3x28		Receptinis	LT/1/98/2903/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2012-04-23	Perregistruotas
2001-10-08	Registruotas